欧洲疫苗研发基础设施的潜在商业模式及其估计的社会经济影响
Stefan Jungbluth1, William Martin1, Monika Slezak1
1European Vaccine Initiative (EVI), Heidelberg, 69115, Germany.
F1000Research
|February 1, 2024
概括
为疫苗研发 (R&D) 基础设施开发可持续的商业模式至关重要. 我们的研究表明,一种全新的综合模型可以显著减少对公共资金的依赖,并产生重大的社会经济效益.
科学领域:
- 生物医学研究生物医学研究
- 卫生经济学 卫生经济学
- 创新管理 创新管理
背景情况:
- 研究基础设施对于科学进步至关重要,但维护成本昂贵.
- 公共资金是主要来源,需要可持续的替代商业模式.
- 减少对公共融资的依赖对于基础设施的长期可行性至关重要.
研究的目的:
- 为疫苗研发 (R&D) 基础设施开发一个可持续的商业模式.
- 为多个收入来源和降低风险整合多样化的商业模式.
- 评估拟议模型对健康,社会和经济的潜在影响.
主要方法:
- 疫苗研发基础设施商业模式的可行性研究.
- 整合两种不同的商业模式,实现多元化收入.
- 前期影响评估评估健康,社会和经济层面.
主要成果:
- 拟议的综合商业模式显示出具有重大社会经济影响的潜力.
- 根据影响评估,疫苗研发基础设施被认为是值得追求的.
- 开发的模型为研究基础设施的可持续性增强提供了一条途径.
结论:
- 开发的商业模式和影响评估为生物医学研究基础设施提供了宝贵的见解.
- 综合方法可以增强金融可持续性,减少对公共资金的依赖.
- 这项研究支持对关键研究设施的新型资金战略的追求.
相关概念视频
Vaccinations
Overview
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...


